JP2023514242A5 - - Google Patents
Info
- Publication number
- JP2023514242A5 JP2023514242A5 JP2022548941A JP2022548941A JP2023514242A5 JP 2023514242 A5 JP2023514242 A5 JP 2023514242A5 JP 2022548941 A JP2022548941 A JP 2022548941A JP 2022548941 A JP2022548941 A JP 2022548941A JP 2023514242 A5 JP2023514242 A5 JP 2023514242A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- acid molecule
- seq
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062975400P | 2020-02-12 | 2020-02-12 | |
| US62/975,400 | 2020-02-12 | ||
| PCT/US2021/017950 WO2021163556A1 (en) | 2020-02-12 | 2021-02-12 | Compositions and methods for inducible alternative splicing regulation of gene expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514242A JP2023514242A (ja) | 2023-04-05 |
| JP2023514242A5 true JP2023514242A5 (cg-RX-API-DMAC7.html) | 2024-02-21 |
| JP7728772B2 JP7728772B2 (ja) | 2025-08-25 |
Family
ID=77292961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548941A Active JP7728772B2 (ja) | 2020-02-12 | 2021-02-12 | 遺伝子発現の誘導性選択的スプライシング調節のための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230340498A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4103717A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7728772B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220146501A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115605596A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021218807A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3167836A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL295542A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021163556A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210355509A1 (en) * | 2018-08-07 | 2021-11-18 | The Children's Hospital Of Philadelphia | Alternative splicing regulation of gene expression and therapeutic methods |
| CN115023242B (zh) | 2019-11-22 | 2025-03-14 | 费城儿童医院 | 腺相关病毒载体变体 |
| WO2023054573A1 (ja) * | 2021-09-30 | 2023-04-06 | 国立大学法人大阪大学 | 相同染色体の一方に特異的なdna欠失を有する細胞を製造する方法 |
| US20250346893A1 (en) * | 2021-10-22 | 2025-11-13 | Fred Hutchinson Cancer Center | Synthetic introns for targeted gene expression |
| CA3254228A1 (en) | 2022-05-18 | 2023-11-23 | The Children's Hospital Of Philadelphia | COMPOSITIONS AND METHODS FOR REGULATING INDUCIBLE ALTERNATIVE SPLICING OF GENE EXPRESSION |
| WO2024060205A1 (zh) * | 2022-09-23 | 2024-03-28 | 北京基驭医疗科技有限公司 | 包含基于小分子药物的可变剪接调节元件的核酸分子 |
| WO2024118610A2 (en) * | 2022-11-28 | 2024-06-06 | Siren Biotechnology, Inc. | Gene therapy vectors for treatment of cancer |
| WO2024173699A2 (en) * | 2023-02-16 | 2024-08-22 | Mammoth Biosciences, Inc. | Compositions for the treatment of spinal muscular atrophy |
| WO2024186892A2 (en) * | 2023-03-06 | 2024-09-12 | The Children's Hospital Of Philadelphia | Regulated control of rna interference by alternative splicing |
| EP4701634A1 (en) | 2023-04-28 | 2026-03-04 | Kriya Therapeutics, Inc. | Riboswitches for regulating gene expression and therapeutic methods of using the same |
| AU2024286618A1 (en) | 2023-06-09 | 2025-10-30 | F. Hoffmann-La Roche Ag | Inducible gene expression system |
| WO2026125303A1 (en) | 2024-12-11 | 2026-06-18 | F. Hoffmann-La Roche Ag | Inducible gene expression system |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838657B2 (en) * | 2004-12-03 | 2010-11-23 | University Of Massachusetts | Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences |
| GB2443186A (en) * | 2006-10-25 | 2008-04-30 | Oxitec Ltd | Expression system for mediating alternative splicing |
| US8633019B2 (en) * | 2008-05-27 | 2014-01-21 | Ptc Therapeutics, Inc. | Methods for treating spinal muscular atrophy |
| EP3406252B1 (en) | 2012-02-10 | 2020-05-13 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| HUE047898T2 (hu) * | 2013-10-28 | 2020-05-28 | Invectys | Telomerázt kódoló DNS vakcina |
| CN108603230A (zh) * | 2015-10-09 | 2018-09-28 | 南安普敦大学 | 基因表达的调节与蛋白质表达失调的筛选 |
| JP2019535789A (ja) * | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス,インコーポレーテッド | Rnaスプライシングを調節する方法 |
| US20210355509A1 (en) * | 2018-08-07 | 2021-11-18 | The Children's Hospital Of Philadelphia | Alternative splicing regulation of gene expression and therapeutic methods |
| CN114174514A (zh) * | 2019-07-25 | 2022-03-11 | 诺华股份有限公司 | 可调节的表达系统 |
| WO2022204471A1 (en) * | 2021-03-26 | 2022-09-29 | Ptc Therapeutics Inc. | Regulation of transgene expression using a small molecule inducible splicing switch |
| CN118480543A (zh) * | 2024-03-01 | 2024-08-13 | 五邑大学 | 一种可变剪接调节元件及其应用 |
-
2021
- 2021-02-12 CN CN202180027946.5A patent/CN115605596A/zh active Pending
- 2021-02-12 EP EP21754225.7A patent/EP4103717A4/en active Pending
- 2021-02-12 US US17/798,851 patent/US20230340498A1/en active Pending
- 2021-02-12 AU AU2021218807A patent/AU2021218807A1/en active Pending
- 2021-02-12 WO PCT/US2021/017950 patent/WO2021163556A1/en not_active Ceased
- 2021-02-12 JP JP2022548941A patent/JP7728772B2/ja active Active
- 2021-02-12 KR KR1020227031120A patent/KR20220146501A/ko active Pending
- 2021-02-12 CA CA3167836A patent/CA3167836A1/en active Pending
- 2021-02-12 IL IL295542A patent/IL295542A/en unknown